Addressing a longstanding controversy in cancer prevention, a large randomized trial showed that low-dose aspirin reduced the risk of colorectal cancer (CRC) in patients with Lynch syndrome just ...

Family history (FH) and pathogenic variants (PVs) in Lynch syndrome (LS) genes are established risk factors of colorectal cancer (CRC). This study evaluates whether newly published polygenic scores ...

ASPIRIN could be prescribed to try to prevent bowel cancer for those in a high-risk group. A Cancer Research UK study found a small daily dose offers protection for people with Lynch syndrome.

Based on these new findings, the National Institute of Health and Care Excellence recommends people with Lynch syndrome consider taking aspirin daily to prevent bowel cancer.

A new trial showed three different doses of aspirin all reduce bowel cancer risk specifically in people with Lynch syndrome. This genetic condition increases a person’s risk for various cancers ...

The National Institute of Health and Care Excellence (NICE) currently recommends that people with Lynch syndrome consider taking aspirin daily to prevent bowel cancer.

Lynch syndrome is the most common cause of hereditary colorectal cancer in the US, with data showing that it accounts for about 3,800 cases each year.

A North East furniture maker who was the first recruit on a groundbreaking cancer trial has celebrated the results 11 years after signing up. Nick James, from Gosforth, signed up to the trial in ...

Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig.